Pfizer is believed to have narrowed the list of agencies in contention for its estimated $75 million Zyrtec anti-allergy drug account. Deutsch
; Kirshenbaum, Bond & Partners; Merkley Newman Harty; Ogilvy & Mather Worldwide; and McCann-Erickson Worldwide are all believed to be finalists. A Pfizer spokeswoman declined comment.
Copyright June 1999, Crain Communications Inc.